2seventy bio, Inc. (TSVT)
May 13, 2025 - TSVT was delisted (reason: acquired by BMY)
5.00
0.00 (0.00%)
Inactive · Last trade price
on May 12, 2025
2seventy bio Employees
2seventy bio had 65 employees as of December 31, 2024. The number of employees decreased by 209 or -76.28% compared to the previous year.
Employees
65
Change (1Y)
-209
Growth (1Y)
-76.28%
Revenue / Employee
$744,077
Profits / Employee
-$62,954
Market Cap
266.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 65 | -209 | -76.28% |
| Dec 31, 2023 | 274 | -151 | -35.53% |
| Dec 31, 2022 | 425 | -12 | -2.75% |
| Dec 31, 2021 | 437 | - | - |
TSVT News
- 12 days ago - 2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb - Business Wire
- 4 weeks ago - 2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT - Business Wire
- 7 weeks ago - 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc. - PRNewsWire
- 2 months ago - Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal - Benzinga
- 2 months ago - Top 3 Health Care Stocks That May Keep You Up At Night In Q1 - Benzinga
- 2 months ago - Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million - Reuters
- 2 months ago - 2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb - Business Wire